UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

Annals of oncology, 2007-12, Vol.18 (12), p.1927-1934

2007

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-21 Expansion of T-cells For Adoptive Immunotherapy of Murine Melanoma

The Journal of surgical research, 2013-02, Vol.179 (2), p.302-303

2013

Link zum Volltext

Verfügbarkeit prüfen

Primary Tumor Resection Decreased the Number of Myeloid Derived Suppressor Cells and Increased CD4 and CD8 Cells

The Journal of surgical research, 2012, Vol.172 (2), p.346-346

2012

Link zum Volltext

Verfügbarkeit prüfen

Stress management in early breast cancer associated with increased endogenous opioids and reduced pro-inflammatory cytokines

Brain, behavior, and immunity, 2010, Vol.24, p.S51-S51

2010

Link zum Volltext

Verfügbarkeit prüfen

Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients: Shin H-C, Han W, Moon H-G, et al (Chung-Ang Univ College of Medicine, Seoul, South Korea; Seoul Natl Univ Hosp, South Korea) Ann Surg Oncol 20:2582-2589, 2013

Breast diseases, 2014, Vol.25 (1), p.65-67

Bear, H.D.

2014

Link zum Volltext

Verfügbarkeit prüfen

122MO Quality of life from the Penelope-B study on high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib

Annals of oncology, 2021-09, Vol.32, p.S410-S411

2021

Link zum Volltext

Verfügbarkeit prüfen

132P Health economic properties of palbociclib in breast cancer patients with high risk of relapse following neoadjuvant therapy: Results from the Penelope-B trial

Annals of oncology, 2021-09, Vol.32, p.S416-S417

2021

Link zum Volltext

Verfügbarkeit prüfen

Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S3-S4

2019

Link zum Volltext

Verfügbarkeit prüfen

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

Breast diseases, 2014, Vol.25 (2), p.146-148

2014

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation

Breast diseases, 2010-01, Vol.21 (2), p.180-181

Bear, H.D.

2010

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation: Boughey JC, Wagner J, Garrett BJ, et al (Univ of Texas M.D. Anderson Cancer Ctr, Houston) Ann Surg Oncol 16:1606-1611, 2009

Breast diseases, 2010, Vol.21 (2), p.180-181

Bear, H.D.

2010

Link zum Volltext

Verfügbarkeit prüfen

Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients

Breast diseases, 2014, Vol.25 (1), p.65-67

Bear, H.D.

2014

Link zum Volltext

Verfügbarkeit prüfen

Taxanes as Primary Chemotherapy for Early Breast Cancer: Meta-analysis of Randomized Trials: Cuppone F, Bria E, Carlini P, et al (“Regina Elena” Natl Cancer Inst, Rome, Italy) Cancer 113:238-246, 2008

Breast diseases, 2009, Vol.20 (1), p.96-98

Bear, H.D.

2009

Link zum Volltext

Verfügbarkeit prüfen

Taxanes as Primary Chemotherapy for Early Breast Cancer: Meta-analysis of Randomized Trials

Breast diseases, 2009-01, Vol.20 (1), p.96-98

Bear, H.D.

2009

Link zum Volltext

Verfügbarkeit prüfen

Expansion of melanoma-specific lymphocytes in alternate gamma chain cytokines: gene expression variances between T cells and T-cell subsets exposed to IL-2 versus IL-7/15

Cancer gene therapy, 2014-10, Vol.21 (10), p.441-447

2014

Link zum Volltext

Verfügbarkeit prüfen

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial: Boughey JC, for the Alliance for Clinical Trials in Oncology (Mayo Clinic, Rochester, MN; et al) JAMA 310:1455-1461, 2013

Breast diseases, 2014, Vol.25 (2), p.146-148

2014

Link zum Volltext

Verfügbarkeit prüfen

1–23 Treatment Trends in Early-Stage Invasive Lobular Carcinoma: A Report From the National Cancer Data Base

Breast diseases, 2006-04, Vol.17 (1), p.60-61

Bear, H.D.

2006

Link zum Volltext

Verfügbarkeit prüfen

Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT

The Journal of nuclear medicine (1978), 2011-09, Vol.52 (9), p.1339-1345

2011

Link zum Volltext

Verfügbarkeit prüfen

Recall reactions and early breast fibrosis with the use of adriamycin following lumpectomy and brachytherapy only for early stage breast cancer

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.159-159

2001

Link zum Volltext

Verfügbarkeit prüfen

Generation of cytotoxic T lymphocytes (CTL) with phorbol ester and calcium ionophore

FASEB Journal (Federation of American Societies for Experimental Biology); (United States), 1991, Vol.5:5

1991

Link zum Volltext

Verfügbarkeit prüfen

Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients

Surgical oncology, 1993-10, Vol.2 (5), p.273-282

1993

Link zum Volltext

Verfügbarkeit prüfen

Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastases

Surgical oncology, 1992-08, Vol.1 (4), p.299-307

1992

Link zum Volltext

Verfügbarkeit prüfen

Methods to Derive the Differential Equation of the Free Surface Boundary

Ground water, 2010-07, Vol.48 (4), p.486-493

2010

Link zum Volltext

Verfügbarkeit prüfen

Methods to Derive the Differential Equation of the Free Surface Boundary

Ground water, 2011-03, Vol.49 (2), p.133-143

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(23)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Female
(3)
Humans
(3)
Life Sciences & Biomedicine
(3)
Oncology
(3)
Science & Technology
(3)
Surgery
(3)
Animals
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Breast Cancer
(2)
Bryostatins
(2)
Cytokines
(2)
Effector Cells
(2)
Gene Expression Profiling
(2)
Lymphocytes
(2)
Macrolides
(2)
Mice
(2)
Neoplasms
(2)
T-Lymphocytes - Drug Effects
(2)
T-Lymphocytes - Immunology
(2)
18f-Fluoropaclitaxel
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

Interleukin-21 Expansion of T-cells For Adoptive Immunotherapy of Murine Melanoma

Primary Tumor Resection Decreased the Number of Myeloid Derived Suppressor Cells and Increased CD4 and CD8 Cells

Stress management in early breast cancer associated with increased endogenous opioids and reduced pro-inflammatory cytokines

Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients: Shin H-C, Han W, Moon H-G, et al (Chung-Ang Univ College of Medicine, Seoul, South Korea; Seoul Natl Univ Hosp, South Korea) Ann Surg Oncol 20:2582-2589, 2013

122MO Quality of life from the Penelope-B study on high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib

132P Health economic properties of palbociclib in breast cancer patients with high risk of relapse following neoadjuvant therapy: Results from the Penelope-B trial

Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation

Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation: Boughey JC, Wagner J, Garrett BJ, et al (Univ of Texas M.D. Anderson Cancer Ctr, Houston) Ann Surg Oncol 16:1606-1611, 2009

Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients

Taxanes as Primary Chemotherapy for Early Breast Cancer: Meta-analysis of Randomized Trials: Cuppone F, Bria E, Carlini P, et al (“Regina Elena” Natl Cancer Inst, Rome, Italy) Cancer 113:238-246, 2008

Taxanes as Primary Chemotherapy for Early Breast Cancer: Meta-analysis of Randomized Trials

Expansion of melanoma-specific lymphocytes in alternate gamma chain cytokines: gene expression variances between T cells and T-cell subsets exposed to IL-2 versus IL-7/15

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial: Boughey JC, for the Alliance for Clinical Trials in Oncology (Mayo Clinic, Rochester, MN; et al) JAMA 310:1455-1461, 2013

1–23 Treatment Trends in Early-Stage Invasive Lobular Carcinoma: A Report From the National Cancer Data Base

Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT

Recall reactions and early breast fibrosis with the use of adriamycin following lumpectomy and brachytherapy only for early stage breast cancer

Generation of cytotoxic T lymphocytes (CTL) with phorbol ester and calcium ionophore

Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients

Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastases

Methods to Derive the Differential Equation of the Free Surface Boundary

Methods to Derive the Differential Equation of the Free Surface Boundary

Suchergebnisse filtern